Systematic Review
Published on 20 Feb 2024
Not only a therapeutic target; mTOR in Hodgkin lymphoma and acute lymphoblastic leukemia
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2024.1304605
- 1,332 views
Type at least 3 characters
1,747 articles
Articles
Review
Published on 20 Feb 2024
Literature review and expert opinion on the treatment of high-risk acute myeloid leukemia in patients who are eligible for intensive chemotherapy
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2024.1367393
- 2,454 views
- 1 citation
Editorial
Published on 19 Feb 2024
Editorial: Covid-19 therapies in patients with hematologic malignancies
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2024.1382268
- 774 views
Review
Published on 19 Feb 2024
The dark side of stemness – the role of hematopoietic stem cells in development of blood malignancies
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2024.1308709
- 3,907 views
- 4 citations
Editorial
Published on 16 Feb 2024
Editorial: Advances in predisposition to bone marrow failure and hematopoietic neoplasms
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2024.1377974
- 1,013 views
Case Report
Published on 13 Feb 2024
Combined antiviral therapy as effective and feasible option in allogenic hematopoietic stem cell transplantation during SARS-COV-2 infection: a case report
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2024.1290614
- 1,080 views
- 4 citations
Case Report
Published on 12 Feb 2024
Case report: Pulse cyclophosphamide for treatment of multi-agent-refractory hepatic graft-versus-host disease
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2024.1329893
- 1,940 views
- 1 citation
Original Research
Published on 12 Feb 2024
Clinical significance of bone marrow involvement by immunoglobulin gene rearrangement in de novo diffuse large B-cell lymphoma: a multicenter retrospective study
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2024.1363385
- 1,232 views
Case Report
Published on 09 Feb 2024
Successful avatrombopag combined with cyclosporine treatment for carboplatin/pegylated liposomal doxorubicin/bevacizumab-induced acquired amegakaryocytic thrombocytopenia in a patient with recurrent ovarian cancer: case report
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2024.1253230
- 1,410 views
- 1 citation
Review
Published on 09 Feb 2024
Azacitidine induced lung injury: report and contemporary discussion on diagnosis and management
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2024.1345492
- 2,650 views
- 2 citations
Review
Published on 09 Feb 2024
Bone damage and health-related quality of life in Hodgkin lymphoma survivors: closing the gaps
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2024.1201595
- 2,257 views
Brief Research Report
Published on 08 Feb 2024
Multimodal machine learning models identify chemotherapy drugs with prospective clinical efficacy in dogs with relapsed B-cell lymphoma
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2024.1304144
- 2,700 views
- 3 citations
Editorial
Published on 07 Feb 2024
Editorial: 50 years of BMT: conditioning regimens and early complications after transplantation
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2024.1369573
- 756 views
- 1 citation
Case Report
Published on 07 Feb 2024
Case report: Safety and efficacy of synergistic treatment using selinexor and azacitidine in patients with atypical chronic myeloid leukemia with resistance to decitabine
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2024.1353818
- 1,343 views
Editorial
Published on 06 Feb 2024
Editorial: Decoding the genome of acute lymphoblastic leukemia through genomic and transcriptomic approaches
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2024.1368676
- 795 views
Brief Research Report
Published on 02 Feb 2024
Enhanced pro-apoptotic activity of rituximab through IBTK silencing in non-Hodgkin lymphoma B-cells
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2024.1339584
- 1,267 views